Better Therapeutics Inc (BTTX)

NASDAQ
Currency in USD
Disclaimer
0.20
0.00(1.38%)
Closed
After Hours
0.200.00(-0.75%)
Day's Range
0.190.22
52 wk Range
0.141.61
Prev. Close
0.19
Open
0.19
Day's Range
0.19-0.22
52 wk Range
0.14-1.61
Volume
1,282,324
Average Vol. (3m)
1,900,294
1-Year Change
-86.58%
Shares Outstanding
47,403,398
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
5.25
Upside +2,525.00%

People Also Watch

1.140
LQR
-13.64%
How do you feel today about BTTX?
Vote to see community's results!
or

Better Therapeutics Inc Company Profile

Better Therapeutics, Inc. is a prescription digital therapeutics (PDT) company. The Company is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The Company's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.